Journal article

Insulin pumps in general practice

Barbora Paldus, Melissa H Lee, David N O'Neal

AUSTRALIAN PRESCRIBER | NATL PRESCRIBING SERVICE LTD | Published : 2018

Abstract

Insulin pumps deliver continuous subcutaneous rapid-acting insulin in a flexible manner. In Australia their main use is in the management of type 1 diabetes. The care of patients with type 1 diabetes on an insulin pump should involve a team approach which includes the GP as well as specialists in diabetes. The GP should therefore understand the terminology associated with insulin pump therapy. Technical support is available from the manufacturer’s helpline. If blood glucose is significantly elevated or the patient is nauseated, blood ketones should be checked. When ketones are elevated the insulin delivery line should be changed, and referral to an emergency department may be needed.

Grants

Funding Acknowledgements

Barbora Paldus has received research support and honoraria from Medtronic, Novo-Nordisk and Sanofi. Melissa Lee has received research support and honoraria from Medtronic. David O'Neal has received research support and is on advisory boards for Medtronic, Novo-Nordisk and Sanofi. He has received honoraria from Medtronic, AMSL, Novo-Nordisk and Sanofi.